Chongqing Intracerebral Hemorrhage Study
Chongqing Intracerebral Hemorrhage Study
The Chongqing intracerebral hemorrhage study is a multi-center, prospective, observational
 study led by professor Qi Li from Chongqing Medical University. Professor Peng Xie will be
 the senior consultant for the study. The Chongqing intracerebral hemorrhage study will focus
 on the epidemiology, natural history, pathogenesis, laboratory, radiological aspects,
 clinical outcomes and the effects of treatment in patients with intracerebral hemorrhage.

 The clinical, laboratory, imaging, genetic and outcome data of patients diagnosed with acute
 intracerebral hemorrhage will be prospectively collected. The prognosis of patients with
 intracerebral hemorrhage will be assessed by using several outcome measure scales at
 different time points.
The Chongqing intracerebral hemorrhage study will try to address several key issues in ICH.
 The baseline clinical data including demographic, disease severity scores, prior drug history
 and relevant medical history, premorbid mRS scores will be prospectively recorded. The
 admission and follow-up imaging data of all registered patients will be saved as Dicom format
 for future use and review. The functional outcomes will be assessed and recorded by
 experienced neurologists.
Inclusion Criteria:

 -  Age >= 18 years

 -  Informed consent to participate in the study

 -  Patients diagnosed with CT-confirmed spontaneous Intracerebral Hemorrhage (ICH)

 -  Patients are willing to participate in the follow up assessment

 Exclusion Criteria:

 -  Did not agree to participate in the study

 -  Secondary ICH to hemorrhagic infarction or tumor bleeding etc.

 -  Traumatic ICH